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1. Introduction 
Iron is an element of crucial importance to living cells. It has incompletely filled ‘d’ orbitals 
and exists in a range of oxidation states, the most common being ferrous [Fe II (d6)] and 
ferric [Fe III(d5)] forms. By virtue of this unique electrochemical property, iron is an ideal 
redox active cofactor for many biological processes and fundamental biochemical activities 
in all cells. It can associate with proteins; bind to oxygen (O2), transfer electrons and mediate 
catalytic reactions. Enzymes of the citric acid cycle – succinate dehydrogenase and aconitase 
are iron-dependent. Iron is a critical component of heme in hemoglobin (Hb), myoglobin, 
cytochromes as well as iron–sulfur complexes of the electron transport chain. Iron is also 
required for activity of ribonucleoside reductase, the rate-limiting enzyme of the first 
metabolic reaction committed to DNA synthesis. Therefore, iron plays an important role in 
metabolic processes including O2 transport, electron transport, oxidative phosphorylation 
and energy production, xenobiotic metabolism, DNA synthesis, cell growth, apoptosis, gene 
regulation and inflammation (Zhang and Enns, 2006; Cairo and Recalcati, 2007; He et al., 
2007; Outten and Theil, 2009; Wang and Pantopoulos, 2011). In the central nervous system, 
iron is required for myelogenesis and myelin maintenance by oligodendrocytes. It is also a 
necessary cofactor for the synthesis of neurotransmitters, dopamine, norepinephrine and 
serotonin (He et al., 2007). Therefore deficiency of iron can result in myriad disorders. Even 
mild iron deficiency can adversely affect cognitive performance, behavior, physical growth 
of infants, preschool and school age children and physical work capacity and work 
performance of adults (Brabin et al, 2001; Haas and Brownlie, 2001). 
2. Iron homeostasis 
The redox reactivity of iron makes it extremely useful but the same property makes it a toxic 
entity, because of its propensity to generate free radicals if it is not tightly bound and/or it is 
present in excess. Due to this dual nature, the human body possesses elegant and elaborate 
control mechanisms to maintain iron homeostasis by coordinately regulating iron 
absorption, iron recycling and mobilization of stored iron. Disruption of these processes can 
result in deviation from normal iron levels both systemically and at cellular level, which can 
lead to deleterious consequences. 
Homeostasis of all essential metal ions share common features. However, compared to other 
metals, the body contains much higher levels of iron (3.5 - 4 g of iron versus 100 mg of 
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copper), aqueous ferric ions exhibit low solubility and unlike other metals, excess iron is not 
actively excreted via the kidney. Also free iron can catalyze formation of reactive oxygen 
species (ROS) and must be safely bound by specialized proteins. Therefore additional iron-
specific homeostatic features are required (Theil and Goss, 2009; Wessling-Resnick, 2010). 
Iron homeostasis must be tightly controlled at both systemic and cellular levels to provide 
optimum amounts of iron at all times and yet maintain the delicate balance between iron 
nutrition and toxicity, especially because the human body does not possess mechanisms for 
getting rid of the excess metal. 
(a)Systemic homeostasis: Maintenance of stable extracellular iron concentration requires the 
coordinated regulation of iron transport into plasma from (i) dietary iron absorbed in the 
intestines (ii) recycled senescent red blood cells (RBC) and (iii) storage in hepatocytes 
(Figure 1). A major indicator and determinant of systemic iron homeostasis is the saturation 
of plasma transferrin (Tf). Saturation levels are predominantly determined by the amount of 
iron entering from the above three sources and the amount utilized for erythropoiesis 
(Mucken et al., 2008).  
 
DcytB- Ferric Reductase Enzyme- Duodenal cytochrome B. DMT- Divalent Metal Transporter. PCBP- 
Poly(rc)-binding proteine. FPN- Ferroportin 
*regulated by Hepicidin 
Fig. 1. Systemic Iron Homeostasis 
Intestinal absorption of dietary iron involves transport across the apical membrane followed 
by translocation through the cytoplasm and across the basolateral membrane into portal 
circulation. Non-heme iron which comprises a major component of dietary iron is taken up 
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from the lumen via the transmembrane protein divalent metal transporter (DMT1) located at 
the enterocyte apical membrane and actively transported as Fe (II) ion. Prior to transport, 
dietary Fe (III) is reduced by the ferric reductase enzyme – duodenal cytochrome B (DCytb) 
(Knutson, 2010). The percentage of iron absorbed from the amount ingested is generally 
higher in case of heme than non-heme iron. As the iron intake increases, the percent of 
ingested dose that is absorbed reduces; however, the absolute amount absorbed and likely 
to enter systemic circulation is more when intakes are high as encountered in 
supplementation and perhaps with fortified foods. Within the enterocyte, due to its reactive 
nature, iron is bound to carrier proteins- poly(r c) -binding protein (PCBP-1) which acts as a 
cytoplasmic chaperon in delivering excess iron to ferritin (Shi et al., 2010). Apparently 
PCBP1 translocates iron to the basolateral membrane where iron is transported out of the 
enterocytes by the iron export protein ferroportin (FPN1). Hephaestin is thought to oxidize 
Fe (II) to Fe (III) which is rapidly sequestered by apotransferrin (Knutson, 2010; 
Muchenthaler, Galy and Hentz, 2008).  
Intestinal sources provide only 1-2 mg of iron per day. The daily demand for 20 mg of iron 
for erythropoiesis is largely met by recycled iron from senescent erythrocytes processed by 
the reticuloendothelial system (RES) consisting of specialized macrophages present mainly 
in the liver, spleen and bone marrow. Within macrophages, heme derived from 
phagocytized RBCs is catalyzed by hemeoxygenase (HO). The liberated iron is released via 
FPN1, donated to Tf and reutilized (Kohgo et al., 2008; Tanna and Miller, 2010). The iron 
that is not used for metabolic purposes is stored in ferritin. The RES represents a major iron 
storage compartment. Ferritin messenger RNAs (mRNAs) are among the most abundant 
mRNAs in monocyte-derived macrophages. Liver has a high iron storage capacity and 
accumulates iron mostly in the periportal regions with a decreasing gradient towards the 
centrilobular areas. Iron stores are depleted in case of increased requirements or excessive 
iron loss (Muckenthaler, Galy and Hentz, 2008). 
Iron export from duodenal enterocytes, macrophages and hepatocytes through FPNI 
appears to be a limiting step, modulated by the peptide hormone, hepcidin. Binding of 
hepcidin to FPN1 triggers the internalization and degradation of the receptor-ligand 
complex. Once internalized, the hepcidin-FPN1 complex is degraded in lysosomes and 
cellular iron export ceases (Nemeth and Ganz, 2009; Knutson, 2010). Hepcidin expression 
is regulated by a number of proteins in response to both extracellular and intracellular 
iron (Figure 2). Two main iron-related signaling pathways, one involving bone 
morphogenetic proteins (BMPs – these comprise a group of at least 20 soluble molecules 
belonging to the transforming growth factor β superfamily) and the other dependent on 
transferrin receptor II (TfRII) regulate hepcidin regulation. Iron sensing by BMP pathway 
is mediated through BMP-6, as their levels in mice increased with dietary iron 
overloading and decreased with deficiency (Kantz et al., 2008). BMP-6 binds to BMP 
receptor (BMPR) complex comprised of BMPRI and BMPRII. After binding of BMP-6, 
BMPRII phosphorylates BMPRI which then propagates the signal by catalyzing 
phosphorylation of cytoplasmic Smad1/Smad5/Smad8. Its association with the common 
mediator Smad4 is followed by translocation to the nucleus where they act as 
transcription factors. BMP signaling is modulated by coreceptor hemojuvelin (HJV) a cell 
surface protein (Knutson, 2010). All these proteins are important for hepcidin expression. 
Disruption of Smad 4 and HJV in mice have been reported to result in iron overload 
(Nemeth and Ganz, 2009). 
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HJV- Hemojuvenil, BMP Bone Morphogenic Protein, BMPR- Bone Morphogenic receptor, FPN- 
ferroportin 
Fig. 2. Regulation of Hepidin Expression 
Hepcidin regulation by the TfRII dependent pathway requires holotransferrin and high-Fe 
gene (HFE) which shuttles between TfRI and TfRII depending on the holotransferrin 
concentration. In high iron conditions, holotransferrin binds to TfRI, displaces HFE and 
allows it to interact with TfRII. Gao et al., (2000) suggested that interaction between TfRII 
and HFE is required for hepcidin induction in response to iron. There appears to be 
crosstalk between the BMP and TfRII dependent signaling converging into a common 
pathway for hepcidin expression in response to iron (Nemeth and Ganz, 2009; Knutson, 
2010). Hepcidin expression is apparently regulated by iron stores, although the mechanism 
of intracellular sensing is unclear. Hepcidin is down regulated in response to iron 
deprivation but how this occurs remains to be fully elucidated. Cell surface HJV appears to 
be cleared by Matriptase-2, thereby reducing BMP signaling. Matripatase deficiency leads to 
iron overload phenotypes (Knutson, 2010). 
Hepcidin expression is suppressed in anemias with ineffective erythropoiesis, mediated by 
proteins produced by erythroid precursors. Hypoxia also decreases hepcidin, being 
modulated by hypoxia-inducible factor. However hepcidin synthesis rapidly increases 
during infection and inflammation (Nemeth and Ganz, 2009). Inappropriate products of 
hepcidin have been implicated in pathogenesis of various iron disorders.  
(b) Cellular homeostasis: The cytosolic iron pool is highly regulated because it is an 
important source of iron for numerous cytosolic and nuclear iron proteins, as well as being a 
source from which mitochondria and other organelles derive iron (Rouault and Cooperman, 
2006). Cellular iron levels are balanced by divergent yet coordinated regulation of proteins 
involved in iron uptake (TfR), export, storage (ferritin) and distribution. Within cells, iron is 
stored in ferritin. Also, labile iron pool (LIP) is present within cells. Most LIP is free iron 
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bound to small organic chelators - citrate or adenosine phosphate, carboxylate, 
polypeptides, (Kohgr et al., 2008; Jiang et al., 2009). LIP is biologically active in intracellular 
metabolism but toxic if present in excess. Maintenance of appropriate LIP levels is critical 
for homeostasis (Mackenzie, Iwasaki and Tsuji, 2008). 
Iron regulatory proteins (IRP) are critical components of a sensory and regulatory network 
controlling iron homeostasis by exerting genetic control at multiple steps (Goforth et 
al.,2010). The expression of TfR and ferritin are coordinately regulated upon binding of IRP1 
and IRP2 to iron regulatory elements (IRE) in the untranslated regions (UTRs) of their 
respective genes. IRPs are activated by iron deficient conditions, bind to their target IREs 
and modulate translation of mRNA (Figure 3). The location of IREs in target mRNA 
determines whether regulation is positive or negative. In case of TfR1 mRNA, five IREs are 
located in 3' UTR whereas the mRNA coding for ferritin contains a single IRE in the 5' UTR. 
When iron is depleted, IRE-IRP interaction at the 3' UTR of TfR1 stabilizes mRNA, while 
imposing a steric blockade to ferritin mRNA translation. As a result, TfR1 is upregulated 
and stimulates acquisition of iron from plasma Tf to counteract low iron levels. 
Simultaneously ferritin synthesis is inhibited as storage of iron is not needed. 
 
Fig. 3. Iron Status and IRP Regulation of Transferrin Receptors and Ferritin Synthesis 
Conversely, when iron concentration is high, IRPs are inactivated resulting in degradation 
of TfR1 mRNA while translation of ferritin mRNA occurs. Thus when iron levels exceed the 
cellular needs, the IRE/IRP switch minimizes iron uptake and promotes iron storage 
(Mackenzie, Iwasaki and Tsuji, 2008; Wang and Pantopoulos, 2011). However, in erythroid 
progenitor cells which require high amounts of iron for heme synthesis, TfR1 stability is 
uncoupled from iron supply and TfR1 level is transcriptionally regulated by erythroid active 
element in its promoter region (Wang and Pantopoulos, 2011). Also TfR1 is regulated in 
hypoxic conditions, wherein dimerized hypoxia-induced factors (HIF-1α and HIF 1β) bind 
to hypoxia response element located upstream of the transcription start site 
(Mackenzie,Iwasaki and Tsuji, 2008). 
IRPs, in addition to modulating ferritin and TfR1 levels can regulate the mRNAs or other 
proteins required for iron utilization (erythroid 5-aminolevulanata synthase), iron uptake 
(DMT1) and export (FPN1). DMT1 mRNA has IRE in its 3' UTR and is upregulated by iron 
deficiency while the other two proteins have IREs in their 5' UTR and are therefore 
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upregulated under high iron conditions (Cairo and Recalcati, 2007; Wang and Pantopoulos, 
2011). It appears that the functional significance of IRE/IRP system is beyond cellular iron 
uptake and storage. The regulation of FPN1 at the basolateral surface of enterocytes by both 
IRE/IRP and hepcidin indicates that the two regulatory systems are interconnected 
(Muckenthaler et al., 2008). Similar mechanisms may apply to other cells and work is 
warranted to understand the functional interconnection between hepcidin and IRE/IRP 
systems. 
3. Iron as a pro-oxidant 
A variety of mechanisms tightly regulate iron homeostasis in the human body. However, 
iron can be toxic if its level and/or distribution are not carefully regulated. Iron toxicity is 
developed through the production of (ROS). ROS are formed during normal cellular 
metabolism. Superoxide anion (O2-) is generated continuously by the mitochondrial 
electron transport system, myeloid cells as well as during several cellular oxidase catalyzed 
reactions. Mitochondrial electron transport system is not the only electron transport system 
producing O2- . Non mitochondrial electron transport chains such as mono oxygenase 
system (microsomal or P450), photosynthetic electron transport chain and others are critically 
important. Besides xanthine oxidase, NADPH oxidase is one of the major sources of O2- , 
while other oxidases mainly produce hydrogen peroxide (H2O2). H2O2 is generated as a 
result of enzymatic (superoxide dismutase) and non-enzymatic destruction of superoxide 
anions. Both O2- and H2O2 are found in extracellular spaces and in blood. Since H2O2 is an 
uncharged compound of low molecular mass, it is believed that it may be capable of freely 
crossing biological membranes and diffusing considerable distance from its site of 
production. However, further work is warranted to confirm the same (Branco et al., 2004; 
Lushchak, 2011). O2- being negatively charged is unable to cross the biological membrane 
whereas its protonated form HO• can. These molecules are not particularly reactive by 
themselves. It is the interaction of these partially reduced forms of oxygen with transition 
elements including iron, which lead to the production of highly damaging radicals. The 
most important reaction of H2O2 with free or poorly liganded Fe(II) is the Fenton reaction, 
generating the highly reactive hydroxyl ions.  
 Fe (II) + H2O2                                      Fe (III) + OH- + HO• (1) 
Superoxide can also react with ferric iron in the Haber – Weiss reaction to produce Fe (II) 
again thereby effecting redox cycling.  
  O2•- + Fe (III)                         O2 + Fe (II) (2) 
Further, ascorbic acid has a number of known interactions with metal ions. Ascorbate can 
replace O2•- within the cell for reducing the Fe (III) to Fe (II), thereby facilitating the Fenton 
reaction. Also, metal ion catalysis of oxidation of ascorbic acid leads to formation of H2O2, 
ultimately generating hydroxyl ions. This generation of hydroxyl ions from the simple 
system containing metal ions, ascorbic acid and oxygen has potentially deleterious 
consequences.  
Hydroxyl radical (HO˙) is highly toxic among the partially reduced oxygen species. It reacts 
with all kinds of biological macromolecules including cellular DNA, protein, carbohydrates 
and lipids. In the nucleus, hydroxyl radicals cause DNA damage, especially double strand 
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breaks as well as chemical changes in deoxyribose, purines and pyrimidines. Hydroxyl 
radical can be added onto C-8 of guanine leading to guanine modification. 8-hydroxy-
deoxyguanosine is an important indicator of DNA damage caused by iron-mediated Fenton 
reaction. Many of the damaged proteins are enzymes, hence critical cellular functions 
including ATP generation are adversely affected. Fe (II) reacting with unsaturated fatty 
acids in the presence of H2O2 can initiate lipid peroxidation cascade in biological 
membranes and lipoproteins by production of HO•. Lipid peroxidation increases membrane 
fragility of cell organelles such as mitochondria, lysosomes and endoplasmic reticulum 
leading to impaired cell function (Fardy and Silverman, 1995; Casanueva and Viteri,2003; 
Kell, 2009 and de La Rosa et al., 2008). Thus HO˙ mediate many higher level manifestations 
of tissue damage, disease and organ failure and ultimately death. 
Normally, the potential toxicity of iron is minimal because it is complexed with Tf in plasma 
and with ferritin which “minimizes opportunities for uncontrolled iron dioxygen chemistry 
and oxidative stress”, within the cells (Kapralov et al, 2009). In addition, there are several 
chaperones and iron-binding proteins, reducing the chances of free or unligated iron 
becoming available to participate in the Fenton reaction. However, any small amount of 
‘free iron’ due to elevated iron levels or released due to specific mechanisms that operate 
during iron deficiency or dysregulation of iron homeostasis, can increase risk of iron-
induced oxidative stress. 
3.1 Iron deficiency and oxidative stress 
In iron-deficiency anemia, the lifespan of the RBCs is reduced. There is increased membrane 
stiffness and a decrease in deformability, thus making it relatively difficult for the RBCs to 
pass through the spleen. Thus in iron deficiency there is suicidal death of RBCs. This will 
liberate iron which increases the potential for oxidative stress. In turn, the presence of 
oxidative stress increases membrane stiffness and decreases deformability, setting up a 
vicious cycle. Further, there is increased lipid peroxidation, combined with depletion of 
antioxidant enzymes such as glutathione peroxidase, exacerbating the production of ROS. 
With less number of RBCs and reduced Hb, there is lower partial pressure of oxygen. The 
partially oxygenated Hb increases autooxidation of Hb which is converted to 
methemoglobin and superoxide is generated. Heme degradation has been reported to 
correlate with immunoglobulin G binding to the RBC membrane, which in turn is associated 
with denaturation of Hb. Denatured Hb and heme degradation products as well as free iron, 
promote removal of RBCs from circulation. Since the ROS concentration can be increased 
near the membrane, not only are the RBCs themselves damaged, ROS can be released to the 
vasculature and neighboring tissues (Nagababu et al., 2008).  
3.2 Elevated body iron and oxidative stress 
Iron stores tend to increase with age (Kell, 2009). Hofera et al., (2008) studied the iron 
content and RNA oxidation in skeletal muscle of 6m and 32m old Fischer 344/Brown 
Norway rats. They observed that with age, non-heme iron levels increased by 233% and 
RNA oxidation by 85%. Simultaneously, HJV and TfR1 decreased by 37% and 87%, 
respectively. There appears to be dysregulation of iron homeostasis with age, favoring 
increased intracellular free iron which in turn can induce oxidative stress. It has been shown 
that lysosomes are a source of rapidly mobilized, chelatable iron, with accumulation of iron 
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being higher with ageing. Lipofuscin, an age-related iron rich pigment is non-degradable 
and not hydrolyzed by lysosomal enzymes. As a result, lipofuscin accumulates in the 
lysosomes. Lysosomes do not have the capacity to remove intralysosomal iron bound to 
lipofuscin, leading to excessive iron accumulation. This accumulation is evident in the RES, 
hepatocytes and post-mitotic cells such as neurons. Low internal pH i.e. 4 to 5 , presence of 
reducing equivalents, such as cysteine, ascorbic acid and glutathione favour intralysosomal 
Fenton reaction (Kurz et al., 2008). Further, iron is rapidly taken up into mitochondria by 
calcium uniporters where it catalyzes the ROS cascade (Uchiyama et al., 2008). ROS 
formation initiates mitochondrial permeability, depolarization, uncoupling of oxidative 
phosphorylation, mitochondrial swelling followed by membrane rupture, ultimately 
leading to necrosis or apoptosis(de La Rosa et al., 2008; Uchiyama et al., 2008). Thus the 
process of ageing and the associated morbidity depends on the oxidative stress-related 
alterations occurring in long-lived post-mitotic cells.  
In women, besides the normal process of ageing, menopause also contributes to iron 
accumulation. Three-fold higher ferritin values have been reported in post-menopausal 
women compared to pre-menopausal women (Crist et al., 2009). Ferritin sequesters 
potentially reactive iron and is cytoprotective. Ferritin is autophagocytosed and degraded 
through lysosomal pathway to liberate iron which is then transported to the cytosol (Kurtz 
et al., 2004). Aberrant release of ferritin iron may lead to production of ROS (Mackenzie et 
al., 2008). Jiang, Pelle and Huang (2009) hypothesized that this increase in body iron may 
have a role to play in postmenopausal hot flashes since they found that serum ferritin levels 
were higher among African-American, white, and Hispanic women who reported more hot 
flashes. Iron is involved in heat production. Poor temperature regulation and thereby 
intolerance to cold has been observed in iron deficient persons, due to impaired heat 
production. 
Iron status may be an important determinant for occurrence of breast cancer. In young 
women, deficiency may be linked to breast cancer recurrence whereas in postmenopausal 
women, higher iron may contribute to breast cancer (Jiang, Pelle and Huang, 2009). 
Hemochromatosis has been linked with high risk of osteoporosis. Osteopenia has been 
observed in patients with iron overload although vitamin D status and parathyroid 
hormone levels were normal. Similarly in patients with sickle cell disease, osteoporosis and 
osteopenia have been reported and the low bone mineral density was found to be associated 
with lower Hb and higher levels of ferritin. Iron status may also affect bone health. In 
animal models, both deficiency and excess of iron have been found to affect bone. D’Amelio 
et al., (2008) observed that patients with osteoporosis were iron deficient, had lower serum 
iron and higher Tf levels. A case report suggests that frequent phlebotomies normalized 
serum while the bone mineral density of the lumbar spine increased. 
Iron and oxidative stress may be involved in the dryness, thinning and wrinkling of skin 
during menopause. It has been suggested that iron accumulation in the skin increases 
oxidative stress when the skin is exposed to UV rays. This in turn affects downstream genes 
and increased body iron stores may cause damage and photoaging of skin as well as make 
the skin more susceptible to damage by UV rays. Prolonged exposure to sun and UVrays 
was found to be associated with accumulation of non heme iron while treatment with iron 
chelators reduced the amount of skin damage.  
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Besides ageing, iron supplementation can expose the body, especially mucosal cells to very 
high levels. In this situation, large proportion of iron is retained in the mucosal cell as 
ferritin. However there may be accumulation of small amounts of iron, increasing the risk of 
oxidative stress. Iron supplementation has been shown to generate free radicals in a murine 
model, increasing intestinal susceptibility to oxidative stress (Ianotti et al., 2006). Iron 
accumulation and mucosal abnormalities such as reduction of microvillus height, necrosis 
have been reported in rats having high iron dose, especially those who were previously 
anemic (Casnueva and Viteri, 2003). In addition to local effects, iron supplementation can 
also affect other organs. Studies conducted in rats have indicated that there is continuous 
absorption of small proportion of supplemental iron at a rate higher than the normal, 
probably by passive diffusion. Under such circumstances, iron levels may exceed the 
binding capacity of Tf, giving rise to non-transferrin bound iron (NTB1). NTB1 is taken up 
by liver and has been shown to contribute to iron loading and hemochromatosis (Mackenzie 
et al., 2008). Unlike Tf–bound iron, cellular uptake of NTBI is not dependent on TfR and 
therefore the resulting iron is diffusely distributed throughout the organ (Kohgo et al., 
2008). Whether long-term iron supplementation will have adverse effects in humans is also 
determined by one’s antioxidant status.  
Conversely, oxidative stress itself influences iron metabolism and iron proteins. Intracellular 
iron levels are increased in response to oxidative stress. There is reduction in ferritin 
synthesis, increased expression and uptake of TfR and upregulation of HO-1(Deb et al., 
2009). Hb can act as a peroxidase in the presence of H2O2. Normally, tight regulation 
prevents this from happening, except in case of severe inflammation or generation of 
superoxide radicals by immune cells. Peroxidase activity of Hb may induce self-oxidation of 
proteins, with covalent cross-linking and aggregation of Hb being consequences which can 
induce oxidative stress in plasma and macrophages (Kapralov et al., 2009).  
Oxidative stress and iron have been linked to several pathological states. Herein we review 
the role of ROS and iron in reproduction, the central nervous system and liver. 
4. Reproduction, oxidative stress and iron 
Human reproduction is a complex but not very efficient process, as less than one –third of 
fertilized human embryos have a chance of surviving upto a term delivery (Ruder et al., 
2008). The reproductive process in males and females is regulated by myriad factors- 
nutritional and non-nutritional, with ROS having an important role. Excess generation of 
ROS and oxidative stress can adversely affect normal reproductive processes and 
supplementation with antioxidants may improve menstrual cycle regularity, prevent 
ovulatory disorders as well as enhance fertility (Ruder et al., 2009).  
4.1 Sperm and fertility  
Spermatogenesis is a very active process and about 1000 sperm are generated per second 
(Aitken and Roman, 2008). Corresponding to this high rate of cell division, the germinal 
epithelium mitochondria utilize oxygen. However, poor vascularization of the testes and the 
associated low oxygen tension may provide protection to spermatogenesis and Leydig cell 
steroidogenesis which are susceptible to ROS. Iron-induced lipid peroxidation, protein 
carbonyl expression and depletion of lipid - soluble antioxidants in testicular tissue results 
in disruption of spermatogenesis. 
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Human spermatozoa produce ROS which enhance tyrosine phosphorylation through the 
suppression of tyrosine phosphorylase activity by H2O2 and stimulation of cAMP 
production, that play a role in regulating signal transduction pathways that control sperm 
capacitation. A low, steady state of ROS production appears to be important for gamete cell 
stability (Hsieh et al., 2006) and capacitation (Baker and Aitken, 2005). Seminal fluid is an 
important source of antioxidants (the enzymes superoxide dismutase, catalase, glutathione 
peroxidase and vitamin C, vitamin E, hypotaurine, taurine, L-carnitine and lycopene) which 
are important for protecting spermatozoa from oxidative injury, especially because sperm 
do not possess much cytoplasmic fluid which generally contains the antioxidant enzymes. 
Hence the antioxidant capacity of sperm is relatively poor (Zini et al., 2009). In the event of 
excessive ROS production, a state of oxidative stress ensues. Since spermatozoa contain 
relatively high amounts of unsaturated fatty acids vis-a-vis the low antioxidant capacity, 
they become susceptible to oxidative stress. Persistent infertility has been linked to lipid 
peroxidation of unsaturated fatty acids in the sperm membrane (Hsieh et al., 2006). ROS 
have been associated with impaired metabolism, morphology, motility and male infertility 
(Baker and Aitken, 2005; Hsieh et al., 2006), retention of excess residual amorphous 
cytoplasm that human spermatozoa are not capable of remodeling or discharging. Also, 
oxidative stress results in DNA damage i.e. strand breaks, formation of DNA base adducts 
such as 8-hydroxyl-2′-deoxyguanosine O 6-methylguanine that have been reported to inhibit 
methylation of adjacent cytosine residues which in turn results in DNA hypomethylation 
(Tunc et al., 2009). This adversely affects the sperm’s ability to fertilize.  
ROS may be produced by sperm that are immobile, morphologically abnormal, or 
morphologically normal but functionally abnormal. Hsieh et al.,(2006) reported that sperm 
motility or concentration were negatively correlated with malondialdehyde concentrations, 
an indicator of lipid peroxidation. Zribi et al., (2011) recently reported a positive correlation 
between oxidation and DNA fragmentation in a study wherein 21 nonasthenozoospermic 
(sperm motility ≥ 50%) were compared with 34 asthenozoospermic (sperm motility < 50%). 
DNA fragmentation was found to be negatively correlated with several parameters of sperm 
motility and vitality.  
Administration of high dose of iron to male mice was reported to induce a dominant lethal 
effect of male mice characterized by high embryonic loss in females that were mated with 
male mice exposed to iron. The authors postulated that this embryonic loss was due to non-
viable embryos. Lucesoli et al., (1999) exposed male rats to varying doses of iron dextran 
(250 to 1000 mg per kilogram of body weight) administered intraperitoneally. Iron was 
found to accumulate in the sperm and other testes cells. In the group administered the 
highest dose, spermatogenesis was markedly lower and concentrations of antioxidants 
(alpha-tocopherol, ubiquinol-9, and ubiquinol-10) in the testes were inversely correlated 
with oxidation. Oxidative protein products viz protein thiols and protein-associated 
carbonyls were higher in rats exposed to the high iron dose (Doreswamy and Muralidhara, 
2005). Supplementation with alpha–tocopherol partially mitigated the oxidative damage 
caused by chronic iron intoxication. 
Wise and coworkers (2003) observed in boars that concentrations of iron and ferritin were 
higher in small testes, with a decrease as testes weight increased. With increasing testicular 
iron concentrations, sperm production declined. These authors cited reports in the literature 
that human males with ǃ-thalassaemia major have decreased pituitary function from Fe 
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overload, and serum ferritin is highly correlated with the presence of hypogonadism. 
Doreswamy and Muralidhara (2005) administered acute sub-lethal doses of iron dextran to 
adult mice (50, 100 and 200 mg per kilogram of body weight). Multiple doses induced increase 
in lipid peroxidation in mitochondrial and microsomal fractions. There was significantly 
higher DNA damage in testes indicated by increased single strand breaks. Although sperm 
count remained unaffected, there was a 3- to 7-fold increase in abnormal sperm. The authors 
attributed the genotoxic consequences to early oxidative damage in testis due to iron overload. 
Thus, iron overload leads to oxidative stress that damage sperm DNA, making the embryos 
non-viable(Aitken and Roman, 2008). Therefore, several investigators have examined the effect 
of antioxidant supplements. Some investigators have observed that short term 
supplementation with antioxidants to men with high levels of sperm damage, resulted in 
better fertility potential and improved pregnancy rates (Zini et al., 2009). Tunc et al., (2009) 
compared 45 men with known male factor infertility with 12 fertile controls who were sperm 
donors. They were given a capsule containing 500 μg of folate 100 mg of Vitamin C, Vitamin E 
- 400 IU, Lycopene - 6 mg, zinc -25 mg, selenium - 26 μg, and garlic oil -33 μg for three months 
in order to cover one full cycle of spermatogenesis. The authors reported that the supplement 
significantly improved sperm DNA integrity and methylation. Recently, 690 infertile men with 
primary or secondary male factor infertility for at least one year, were given a daily 
supplement of 200 μg with vitamin E(400 units) for more than 3 months by Moslemi et 
al.,(2011). The investigators observed that in about half the subjects, there were improvements 
in sperm motility, and/ or morphology. In one-tenth of the cases, spontaneous pregnancy 
occurred compared to none in the control group.  
As in case of males, ROS play a role in the entire lifecycle of females, affecting various 
physiological functions from oocyte maturation, modulation of ovarian germ cell, stromal 
cell physiology, transcription factors, ovarian steroidogenesis, corpus luteal function and 
luteolysis, implantation, formation of blastocyst, pregnancy, parturition to perhaps even 
menopause. Iron nutriture during pregnancy is of concern since iron requirements during 
pregnancy are significantly higher than in the non- pregnant state and iron deficiency 
during pregnancy has been linked to maternal morbidity and mortality, low birth weight 
and infant mortality (Ramakrishna, 2002). Aune et al., (2004) studied 19 healthy pregnant 
women given 26 mg of iron (as ferrous aspartate) per day. After 4 weeks, total antioxidant 
activity and conjugated diene levels (indicative of lipid peroxidation) were raised. 
Casanueva and Viteri(2003) reported that supplementation of pregnant women with 100 mg 
iron and 500 mg vitamin C in the third trimester of pregnancy was associated with higher 
levels of serum iron and thiobarbituric acid-reactive substances than in the control group. 
Vyas (2005) observed an increase in lipid peroxide levels with an increase in serum iron of 
85 pregnant Indian women from lower socio-economic strata. Women who delivered at 
term tended to have slightly higher levels of lipid peroxides than those who delivered 
preterm. However, there are few studies in the literature on iron deficiency and oxidative 
stress, per se particularly related to pregnancy. Many investigators have reported on iron 
proteins and their roles in oxidative stress, which is reviewed in this section. 
4.2 ROS and pregnancy  
Oxidant status may influence early embryonic development. Pregnancy is characterized by 
increased basal oxygen consumption and susceptibility to oxidative stress, although little 
data is available on oxidative stress in the preconception and early conception period. Fetal 
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development and survival depend on the placenta as it plays a pivotal role by anchoring the 
conceptus, providing an interface between the mother and fetus, transfers nutrients, is 
important for exchange of gases, synthesis of a number of hormones and provides an immune 
barrier. Any problems associated with placental growth and differentiation ultimately affect its 
function and therefore fetal growth and development. The placenta itself produces ROS since 
it is rich in mitochondria, is hemomonochorial and allows electrons to pass that are converted 
into O2- radicals (Casanueva and Viteri, 2003; Fuji, et al., 2005; Agarwal et al., 2005). The half 
lives of these ROS differ which influences their diffusion across the placenta. Superoxide is 
unable to diffuse across beyond the cell of its origin/synthesis because of short half life 
whereas the nitric oxide has a higher diffusion distance and can be a paracrine mediator in 
adjacent cells and be potentially more damaging (Myatt, 2010). 
Proliferation and differentiation of trophoblasts and invasion by them is essential for 
placentation. It is important that trophoblasts colonize the endometrium and sequester the 
blood supply that is essential for the developing placenta. There is also considerable 
vascular remodeling in order to provide for the requirements of the developing fetus. In the 
early stages of pregnancy, a low oxygen milieu prevails. This placental hypoxia in the first 
trimester is physiological, regulates both morphogenesis and functioning of the placenta 
and is important for normal embryonic development. Maternal blood flow to the 
intervillous spaces commences only around 11 weeks of gestation (Pringle et al, 2010). This 
increase in oxygen concentration is vital for active placental transport and synthesis of 
proteins required by the rapidly developing fetus in the second and third trimesters (Burton, 
2009). Jauniaux and coworkers (2000) studied 30 women at 7-16 weeks of gestation and 
observed a rapid increase in oxygen tension within the placenta at the end of the first 
trimester. Maternal blood flow starts at the periphery of the placenta and then gradually 
extends towards the centre, accompanied by an increase in the oxygen tension. This is 
associated with increased oxidative stress in the placenta and especially the 
synctiotrophoblast. Physiologically this is necessary for trophoblast differentiation. A 
deviation from this normal phenomenon such as early onset of blood flow would result in 
premature rise in oxidative stress since the placenta at early stages of pregnancy (8-10 
weeks) does not have adequate antioxidant enzymes.  
Further, the low levels of oxygen in the uterus are advantageous in terms of having 
relatively lower metabolic rates and thereby minimizing the production of ROS. However, 
impairment of these processes or hypoxia at later stages in pregnancy is pathological. 
Insufficient trophoblast invasion, defective vascular remodeling in the first trimester have 
been found to increase blood flow, damage villous architecture, increase the risk of 
spontaneous vasoconstriction and ischemia - reperfusion which can result in oxidative stress 
(Burton et al., 2009). Higher intensity of oxidative stress can have adverse effects on the 
developing embryo, and can lead to embryo fragmentation (Jauniaux et al., 2000). In studies 
on in vitro fertilization, fluid from follicles whose oocytes did not fertilize contained higher 
activity of superoxide dismutase than those that fertilized. Also, higher levels of 8-hydroxy-
2-deoxyguanosine, an indicator of DNA damage caused by oxidative stress, have been 
observed in granulosa cells of patients with endometriosis and were associated with lower 
fertilization rates and poor embryo quality (Agarwal et al., 2005).  
Most studies reported in the literature relate oxidative stress to pregnancy complications 
and some to the outcome of pregnancy. The focus in most investigations has been on the 
role of oxidative stress in preeclampsia. 
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4.2.1 Pregnancy complications – Preeclampsia  
During early gestation, the syncytiotrophoblast has low concentrations of antioxidant 
enzymes compared to other villous tissues, making it susceptible to oxidative stress 
(Jauniaux et al., 2000). Hence, disturbances in oxygen tension and ROS can result in 
pregnancy complications. Preeclampsia, miscarriages, preterm labour, birth defects, 
endometriosis and tubal factor infertility, intrauterine growth retardation and stillbirth have 
been linked to insufficient trophoblast invasion, development, vascular remodeling and 
impaired placental development and function (Jauniaux et al., 2003, Szczepanska et al., 2003, 
Pringle et al, 2010) In the event of placental hypoxia, due to defective placentation, ischemic-
reperfusion injury occurs and the ensuing oxidative stress stimulates the release of cytokines 
and prostaglandins. This has been implicated in endothelial cell dysfunction and possible 
development of preeclampsia (Agarwal et al., 2005). In patients with preeclampsia, 
antioxidant nutrient levels as well as antioxidant response was lower while lipid 
peroxidation was higher (Takagi et al, 2004; Aydin et al, 2004 and Mikhail et al, 1994). Also, 
free 9-isoprostane levels that are produced by non-enzymatic random oxidation of tissue 
lipids by ROS were found to be significantly higher in women with preeclampsia as 
compared to healthy pregnant women (Zhang et al., 2008). 
Placentas obtained from women with preeclampsia had higher lipid peroxides and xanthine 
oxidase activity as well as nitrotyrosine residues. Burton (2003, 2009) proposed that 
complications such as preeclampsia and intrauterine growth restriction may be related to 
fluctuations in oxygenation and not hypoxia alone due to inadequate trophoblastic invasion 
which in turn result in spontaneous constriction of the spiral arteries. Cindrova-Davies et al., 
(2007a) observed in an in vitro study that placenta explants exposed to hypoxia and 
reoxygenation, exhibited increased oxidative stress while addition of vitamin E and C 
mitigated it. 
Several events during pregnancy from placentation, maintenance of uterine quiescence, 
regulation of hemodynamic control within the uterus and placenta, protection against 
preeclampsia, regulation of apoptosis and inflammatory cascades in trophoblast cells among 
others are influenced by HO and its degradative products viz biliverdin, carbon monoxide 
and ferrous ions. HO-1 has antioxidative, anti-inflammatory and anti-apoptotic effects. 
Centlow et al., (2008) observed that placental tissue from preeclamptic women exhibited 
increased expression of Hbǂ and HbǄ mRNA than placentas from normal pregnant women. 
Increased number of cells expressed Hb in the preeclamptic patients’ placentas suggesting 
that either the cells were migrating into or out of the vessels or there may be binding sites on 
the vessel walls. Also, the placental vessels in preeclamptic patients had high numbers of 
Hb+ nucleated cells, which were probably fetal erythroblasts migrating in response to the 
poor perfusion and low oxygen levels in the pre eclamptic placenta. The authors postulated 
that if the turnover of Hb producing cells is high, these cells could well release heme into the 
placental blood vessels and extra villous space as evidenced by their observations of high 
Hb levels in the blood vessel lumen of pre eclamptic placentas. In contrast, this phenomenon 
did not occur in the normal control placentas.  
Free heme generates ROS and thus can oxidize lipids including low density lipoproteins 
into cytotoxic peroxides that will damage the endothelium, oxidize membrane proteins 
resulting in increased membrane permeability and lysis of cells. Normally, HO degrades 
free heme but in preeclampsia, it has been observed that there is decreased expression of 
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this enzyme and the activity is also less. This may result in accumulation of heme in the 
placenta. To further exacerbate the situation, carbon monoxide production from heme by 
HO may be less, thus contributing to reduced placental blood flow, inducing inflammatory 
response, activation of nuclear factor (NF)-κB transcription factors by the heme-generated 
ROS. This in turn may stimulate production of adhesion molecules and cytokines, 
recruitment of leukocytes, migration of neutrophils as well as their activation and induce 
further increasing risk of damage. Heme can also induce secretion of tumor necrosis factor-α 
and activate toll like receptor 4 leading to an immune response. 
Gandley and coworkers(2008) reported that levels of placental myeloperoxidase, a 
hemoprotein produced and released by activated monocytes and neutrophils, were elevated 
in 27 placentas obtained from women with preeclampsia compared to normal gestationally - 
matched placentas. Myeloperoxidase may be involved in the generation of potent ROS and 
has been associated with mediation of oxidation of lipoproteins, catalyzing nitration of 
tyrosine residues, depleting endothelially derived nitric oxide, vascular inflammatory 
diseases and utilization of antioxidants. 
4.2.2 Pregnancy outcome  
Zhaoa et al., (2009) observed that early embryonic death in mice occurred when the enzyme 
HO-1 was deficient, indicating a possible role in early placentation or embryonic 
development. The authors suggested that deficiency of this enzyme may also affect 
complement activity and play a role in fetal resorption. Deficiency of this enzyme was 
associated with rise in diastolic blood pressure, and less dilated spiral arteries in the 
placenta.  
Exposure to ROS during organogenesis can increase risk of birth defects. Burton (2009) 
reported that in animals with genetically impaired antioxidant enzyme activity and in 
diabetic rats in whom ROS levels were increased, the offspring had congenital abnormalities 
(Hagay et al. 1995; Eriksson, 1999; Nicol et al. 2000). Slonima and coworkers (2009) 
compared differences in gene expression between euploid fetuses and second trimester 
Down’s syndrome fetuses, in uncultured amniotic fluid supernatant samples and suggested 
that oxidative stress may have a significant role in Down’s syndrome. Prater and colleagues 
(2008) used methylnitrosourea to induce oxidative stress in C57BL/6 mice. They observed 
that several important placental proteins such as Hgf, Kitl, IFNǂ4, Ifrd, and interleukin (IL)-
1ǃ which are important for development of the placenta and fetal skeleton were altered. 
Also there was damage to placental endothelial cells and trophoblasts. In the group given 
methylnitrosourea with quercetin, an antioxidant, the levels of these proteins were 
normalized. Also, in the group treated with methylnitrosourea, the pups had 
disproportionately short limbs as well as distal limb malformations which were not 
observed in the quercetin supplemented group. The authors suggested that oxidative stress 
could alter normal placental osteogenic signaling and skeletal formation in the fetus.  
Guller (2009) reported that in preeclamptic condition, there may be reduced nutrient supply 
to the fetus, resulting in intrauterine growth retardation. Levels of malondialdehyde were 
higher in small for gestational age newborns compared to adequate for gestational age 
controls. Markers of oxidative stress were significantly correlated with maternal Hb. 
Further, SGA newborns had higher number of “unprotected’ erythrocytes i.e. content of 
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antioxidant protectants were lower. This would make the erythrocytes more susceptible to 
lysis which would in turn release heme and increase risk of ROS generation  
During pregnancy, iron supplements are routinely recommended, but there is little direct 
evidence to determine whether iron supplementation would contribute to oxidative stress in 
either direction i.e. mitigate the stress by reducing anemia which leads to oxidative stress or 
produce iron overload which may increase ROS generation (Casaneuva and Viteri, 2003). 
5. Iron and central nervous system 
Neurons are long-lived postmitotic cells which are rarely replaced through division and 
differentiation of stem cells. This permits biological waste materials to accumulate in these 
cells with ageing, possibly because lysosomal degradation is not adequate or unsuccessful, 
resulting in functional decay and ultimately cell death. Among the waste materials that can 
be accumulated are lipofuscin, irreversibly damaged mitochondria and aberrant or 
abnormal proteins with consequent selective loss of neurons which may be age-dependent. 
Abnormal proteins that accumulate are Ab-amyloid neuritic plaques and neurofibrillary 
tangles in Alzheimer’s disease (AD), α-synuclein, and Lewy bodies in Parkinson’s disease 
(PD) (Gaeta and Hilder, 2005). Ageing of such long lived post mitotic cells has been 
attributed ROS formed mostly within the mitochondria. Due to its high content of poly 
unsaturated fatty acids, the brain is very sensitive to attack by ROS. Lipid peroxidation and 
its aldedydic products, 4-hydroxynonenal (4 HNE) and acrolein have been implicated in 
neurological ailments. Due to oxidative stress, there may be cytoskeletal damage, 
mitochondrial dysfunction and altered signal transduction. Neurons stressed and injured by 
free radicals are rendered non-functional, function and transport of mitochondrial to 
synaptic regions is impaired and synaptic function decreases resulting in 
neurodegeneration. The superoxide radical is the most abundant ROS and has been 
reported to play a role in brain edema and hippocampal neuronal death (Ansari et al, 2008). 
Diseased neurons can remain viable for 10 years or longer and as such must have sufficient 
protective mechanisms to maintain normal homeostasis. However, at some point in a 
neurodegenerative disorder, the oxidative insults may overwhelm cellular antioxidant 
defense systems leading to cellular dysfunction and death (Siedlak, 2009). In fact oxidative 
stress is regarded as one of the earliest changes in the pathogenesis of AD that may be 
present several years before the disease overtly manifests itself (Smith et al., 2010). 
5.1 Iron, ROS and neurodegeneration  
The brain is vulnerable to oxidative stress because, not only does it have a high content of 
polyunsaturated fatty acids (George et al., 2009) but also contains substantial amounts of 
iron (Gaeta and Hilder, 2005). The blood brain barrier serves to limit entry of iron into the 
brain, thus protecting it from overload (Wang and Michaelis, 2010). Within the brain, there 
are mechanisms to regulate the cellular iron level ensuring adequate supply to allow normal 
function of the cells and nervous system while protecting them from toxicity. Iron deficiency 
affects cell division of neuronal precursor cells, astrocytes, and oligodendrocytes. However, 
when the amount of iron exceeds what can be safely sequestered by ferritin, heme proteins 
and iron-sulfur clusters; oxidative stress results especially in regions containing higher 
amounts of iron – globus pallidus, substantia nigra, red nucleus, putamen, caudate nucleus. 
It has been suggested that excess iron or “iron invasion” may be the primary event and 
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cause degeneration of axons as well as neuronal cell death. Evidence from studies on 
inherited disorders of iron metabolism indicates that neurodegeneration occurs with iron 
accumulation (Mills et al., 2010). 
Olivares et al., (2009) reported that iron accumulation is probably a primary event and not a 
consequence of degenerative diseases. In a rat model, when FeCl3 was injected into the 
substantia nigra, there was selective decrease in striatal dopamine suggesting that iron is 
responsible for dopaminergic neurodegeneration. The phenomenon was prevented by 
infusion of desferrioxiamine, an iron chelator. Mutations in the gene that codes for a ferritin 
subunit result in a disease similar to PD. Catecholamine neurons are selectively degenerated 
by 6-hydroxydopamine which is oxidized to cytotoxic chatecholaminergic semiquinones and 
quinines along with hydrogen peroxide and hydroxyl radicals. Iron deficient rats were 
resistant to toxicity induced by 6-hydroxydopamine. Further, its toxicity was reversed by an 
iron chelator, desferal. Similarly in iron models of stroke, use of iron chelating agents could 
reduce the infarct size and brain injury as well as improve neurologic outcome (Stankewicz et 
al, 2007). In mice, deletion of the gene encoding for IRP2 which interferes with regulation of 
iron metabolism has been found to result in abnormal iron deposition in the brain, as well as 
ataxia, tremors and neurodegeneration. Similarly mutation in the gene coding for a ferritin 
subunit and polymorphisms in genes related to iron homeostasis have been associated with 
iron deposits, neuronal degradation and sometimes PD (Olivares et al, 2009).  
Another possible mechanism is the ready binding of iron to advanced glycation end-
products that accumulate with age in the endothelial internal elastic lamina or basement 
membrane. Iron and copper can scavenge nitric oxide and thus prevent its action on the 
smooth muscle resulting in prolonged vasoconstriction (Eaton and Qian, 2002). If this occurs 
in the blood vessels of the brain, it could contribute to neurodegeneration and may therefore 
contribute to the efficacy of the iron chelator desferroxiamine in AD (Stankiewicz et al., 
2007).  
Lysosomal (autophagic) degradation is rapid and effective but is not completely successful. 
Even under normal conditions, some iron-catalyzed peroxidation occurs intralysosomally 
(lysosomes are rich in redox-active iron), resulting in oxidative modification of 
autophagocytosed material and yielding lipofuscin, a polymeric compound slowly 
accumulating within ageing postmitotic cells at a rate that is inversely correlated to the 
longevity across species (Kurz et al, 2008). When iron-rich, non-degradable substances like 
lipofuscin and hemosiderin (which is not degradable and composed of polymerized ferritin 
residues) accumulate in some lysosomes, there is an increase in iron content. This increases 
the lysosomes’ sensitivity to ROS.  
The central nervous system contains considerable amounts of iron although the regional 
distribution of the metal differs, thus conferring varying sensitivity to oxidative stress 
(Zecca et al., 2004; Hall et al., 2010). Normally, the cytosolic iron is regulated and maintained 
at a low level adequate to ensure synthesis of essential iron containing molecules and yet to 
prevent free or of redox-active iron at low levels to prevent damage. Although both ferritin 
and Tf have high affinity for iron at neutral pH, the metal dissociates easily from the two 
proteins at pH below 6.0, which may occur in injured areas.  
Whenever there is a requirement for iron, it is taken up by the cell from its surroundings. 
However, in non-dividing cells, iron that is available is determined primarily by turnover 
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and reutilization. Cells are unable to get rid of the intralysosomal iron bound to lipofuscin. 
Thus, over a prolonged period, iron accumulates despite regulation of iron uptake, which is 
especially seen in long-lived postmitotic cells like neurons. Histologic and magnetic 
resonance imaging studies indicate that there is increased iron level in the gray matter in PD 
and AD as well as other neurological disorders. Abnormal iron deposits have been observed 
in neurons and oligodendrocytes of patients with multiple sclerosis, with increased in the 
ferric iron content in the caudate and putamen. Magnetic resonance imaging studies on 
humans indicate a possible relationship between damage to gray matter and iron deposition 
in patients with multiple sclerosis (Stankewicz et al., 2007). Thus, as these cells age and 
especially as the end of their lifespan approaches, they become sensitive to oxidative stress. 
When there is enhanced autophagy, such as when there is repair following injury coexisting 
with oxidative stress, there is more rapid formation of lipofuscin.  
Hemoglobin is another source of catalytically active iron, a situation that may be 
encountered in hemorrhage. The iron released from the Hb is likely responsible for the 
Hb-mediated oxidative stress. In conditions of hypoxia or ischemia, due to brain injury for 
example in children with anoxia or in animal models of stroke, iron deposition has been 
reported in basal ganglia, thalamus, periventricular and subcortical white matter. 
Insufficient oxygen levels increase lactic acid locally which reduces the ability of Tf to 
bind iron and simultaneously result in release of the iron bound to ferritin (Stankewicz et 
al, 2007).  
In addition to directly affecting the brain adversely, oxidative stress may cause damage 
through overexpression of inducible nitric oxide synthase (iNOS) that in turn would 
augment the production of nitric oxide. Nitric oxide reacts with superoxide anion and 
produces the highly reactive peroxynitrite, resulting in oxidation and aggregation of 
proteins. Consequently there can be conformational changes in the proteins exposing 
hydrophobic residues which may result in loss of structural or functional activity, 
accumulation of oxidized proteins in the cytoplasm as aggregates e.g tau and amyloid-ǃ 
aggregates as seen in AD. Mitochondrial dysfunction and damage from intracellularly 
produced ROS may lead to age-related neurodegenerative disease. In mice, mitochondrial 
deficiency of superoxide dismutase was associated with hyperphosphorylation of tau and 
exacerbation of amyloid burden (Melov et al., 2007). 
Increased intensity of oxidative stress results in peroxidation of the lysosomal contents and 
the membrane, rendering the lysosome leaky. This phenomenon may occur even after only 
brief exposure to oxidative stress. Lysosomes contain a fairly high amount of redox active 
iron originating from degraded iron-containing proteins. The low pH in the lysosomes 
favours iron catalysed oxidative reactions. Kurz et al., (2004) stated that ferritin needs to 
undergo autophagocytosis and degradation before the iron the released and incorporated 
into ferritin for storage or in other iron-containing proteins. Each molecule of ferritin can 
store about 4500 atoms of iron. As a result, even if there is a relatively small number of 
autophagocytosed ferritin molecules, there can be substantial reduction of lysosomal iron. 
Autophagy occurs continually, with the degraded lysosomal ferritin being replaced (Kurz et 
al., 2008). Kurz et al., (2004) stated that when the lysosome ruptures, it releases hydrolytic 
enzymes, The rupture also induces coordinated aopoptotic cell death. Besides release of lytic 
enzymes, iron is also released into the cytosol. This iron may reach the nucleus where 
hydroxyl radicals may be generated if the oxidative stress continues.  
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It is not only excess iron and consequent oxidative stress that can induce lysosomal damage. 
Iron depletion has been found to damage lysosomes although it has been suggested that the 
mechanism may be a consequence of other apopotogenic factors (Kurz et al., 2008). Iron has 
been implicated in dysfunction of the central nervous system. Neurodegenerative diseases 
such as PD, AD, amyotrophic lateral sclerosis, Huntington’s disease, Friederich’s ataxia and 
aceruloplasminemia have been linked to iron (Achcar et al., 2011) Sites of neuronal death in 
the brain have been observed to be sites where iron accumulates. In cases with multiple 
sclerosis, redox active iron but not total iron content of cerebrospinal fluid was significantly 
higher. 
Besides this, monoamine oxidase (MAO) has also been linked to oxidative stress (Zecca et 
al., 2004; Mandel et al., 2005). Activity of MAO in both humans and animals is influenced by 
iron levels (Symes et al., 1969; Youdim et al., 1975). MAO, a flavo-protein located on the 
outer mitochondrial membrane, can exist in two forms A and B-the B form activity is greater 
in basal ganglia. In rodents, MAO-A is present in the extraneuronal compartment and 
within the dopaminergic terminals, it plays a role in the metabolism of intraneuronal and 
released dopamine. In the process of its role in oxidative deamination of primary, secondary 
and tertiary amines to the corresponding aldehyde and free amine, H2O2 is generated 
(Moussa, Youdhim and Bakhle, 2006). H2O2 is inactivated in the brain by glutathione 
peroxidase. However, if brain glutathione oxidase levels are low, H2O2 can accumulate and 
participate in the Fenton reaction whereby iron as the ferrous ion, generates hydroxyl 
radicals that are highly active free radicals.  
Both monoamine oxidase activity and brain iron concentration increase with age, thus 
increasing the potential for generation of hydroxyl radicals and oxidative stress with age. 
Mandel et al., (2005) reported increased activity of MAO in patients with PD and AD. In PD, 
samples of substantia nigra from PD patients were found to be deficient in aldehyde 
dehydrogenase . This could lead to accumulation of neural and toxic aldehydes derived 
from dopamine by MAO (Moussa, Youdhim and Bakhle, 2006. Ansari et al (2008) reported 
that oxidative stress results in oxidation of synaptic proteins and has adverse effects on 
synaptic plasticity, connection. Impaired mitochondrial transport to synapses contributes to 
neuronal degeneration and death. Loss of synapsin-I and PSD-95 which influence neuronal 
function and survival was caused by oxidative stress. 
5.2 Parkinson’s disease  
PD is a progressive neurodegenerative disorder. There is degeneration of nigrostratial 
dopaminergic neurons in the substantia nigra, resulting in depletion of dopamine. 
Consequently there is loss of motor functions, formation of intracytoplasmic inclusions 
(Lewy bodies) and Lewy neuritic inclusions (LNs) in the surviving dopaminergic neurons. 
Dopamine is oxidatively deamined to its aldehyde-3,4-dihydroxyphenylacetaldehyde by 
MAO and then to 3,4-dihydroxyphenylacetic acid by aldehyde dehydrogenase. 4-HNE and 
malondialdehyde, products of lipid peroxidation are potent inhibitors of mitochondrial 
dehydrogenase but do not inhibit MAO. Even low levels of oxidative stress yield the aldehyde. 
The aldehyde has been shown to be toxic towards dopaminergic cells via oxidative stress and 
other mechanisms. Thus, cells located close to dopamine neurons such as astrocytes and 
microglia may well be exposed to high concentrations of the aldehyde during or following 
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oxidative stress. The aldehyde may target and modify proteins important for dopamine 
neuron homeostasis including ǂ-synuclein (α-syn) (Jinsmaa et al, 2009). 
LNs are derived from fibrillar aggregates of ǂ-syn belonging to the synuclein family. ǂ-syn 
is largely expressed at presynaptic terminals specially in some parts of the brain like 
neocortex, hippocampus, striatum, thalamus and cerebellum. The central hydrophobic 
peptide in ǂ-syn has been implicated in Alzheimer’s disease and is an important component 
of amyloid plaques. Oligomers of ǂ- syn through crosslinking of di-tyrosine may occur 
through nitration, an oxidative mechanism. Nitrated ǂ-syn is not processed well by 
proteases and has been detected in brains of persons with PD. If ǂ-syn aggregates, there is 
decrease in the soluble ǂ-syn and it ultimately permits large amounts of dopamine to enter 
the cell, consequently increasing the potential for generating ROS. 
Further iron associated proteins and receptors have been reported to be upregulated in the 
striatum and substantia nigra of patients with PD. Regan et al. (2008) reported that ferritin 
levels in the central nervous system increased with normal aging. However, in patients with 
PD, there was little increase in the substantia nigra, although there was iron accumulation, 
suggesting that less sequestration into ferritin may make the brain vulnerable to toxic effects 
of iron and oxidative stress. These authors observed an inverse relationship between cell 
death in mixed cortical cultures and ferritin expression. 
Neuromelanin is a pigment that is protective against oxidative stress because it can bind and 
concentrate transition metals like iron. In normal brain, only 50% of this pigment is 
saturated with iron, such that it can still chelate iron in the neurons if there is an onslaught 
of the mineral. However, in PD, when brain iron concentration is increased, the pigment 
may become saturated and iron would be bound to low affinity sites, so that some amount 
of the bound iron is redox-active and potentially toxic(Gaeta and Hider, 2005). 
Brain tissues of patients with Parkinson’s have been found to contain substantial amounts of 
iron in the substantia nigra (a 25% to 100% increase) compared to healthy age-matched 
controls. ǂ-syn can interact with cations and this binding in turn catalyzes protein aggregation 
(Stankewicz et al., 2008). Metal-induced aggregation is attributable to the oxidation by redox 
metals. Increase in the redox active metal, like iron results in oxidation and therefore in the 
degeneration of dopaminergic neurons in the substantia nigra. Besides 
aggregation/oligomerization of ǂ-syn, other effects of oxidation can be mitochondrial 
dysfunction, cytotoxicity and increase in cytosolic free Ca2+ resulting in cell death. Redox 
elements like iron also accelerate the enzymatic and non-enzymatic catabolism of dopamine. 
High iron concentrations in the substantia nigra can catalyze conversion of hydrogen peroxide 
during catabolism of dopamine with the production of highly reactive hydroxyl radicals.  
Oxidative stress can further exacerbate the situation by removal of iron from ferritin, Hb 
and cytochrome c peroxides, iron sulfur protein by the action of ONOO-, which in turn will 
increase the iron levels. Iron also catalyses conversion of excess dopamine to neuromelanin. 
This is an insoluble pigment that has been found to accumulate in aged dopaminergi neurons. 
Neuromelanin sequesters redox ions that have affinity for ferric ions. If it is bound to an excess 
of ferric ions, neuromelanin functions like a prooxidant, reduces the ferric to ferrous and 
increases the amount of iron available to react with H2O2 (Olivares et al., 2009). Iron not only 
induces oxidative stress but damages proteins, membranes, and nucleic acids and eventually 
leads dopaminergic neuron death in the substantia nigra (Logroscino et al., 2008). 
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Powers et al (2009) studied dietary intakes of 266 men and 154 women who were newly 
diagnosed patients with idiopathic PD. They were compared with a control group 
consisting of 351 men and 209 women. In men, the highest level of iron intake was 
associated with increased risk of PD. A combination of low saturated fat intake with high 
iron was linked to moderate risk in both sexes, with the association being stronger for men. 
The authors suggested that cholesterol is a protective factor for PD, possibly through the 
relationship between cholesterol and coenzyme Q10 which is an antioxidant and may 
reduce oxidative stress generated by dopamine metabolism. 
Brains of patients with PD have been observed to have increased amounts of nonheme iron 
compared to controls but ferritin and Tf content were low. Logroscino and coworkers (2008) 
stated that this may indicate that there is altered regulation of synthesis of proteins including 
ferritin that are involved in iron metabolism. The low ferritin levels in the tissues may reflect 
inadequate neuronal response to the excess amount of nonheme iron entering the brain. 
Alternatively in PD there may be disturbance in the mechanism for iron transport through the 
neuronal membrane. Lactoferrin activity was found to be significantly higher in 
patients’mesencephalon where loss of dopamine is more severe. Gorell et al., (1999) reported 
that in autosomal recessive juvenile Parkinsonism associated with mutations in the Parkin 
gene, iron levels were increased in the substantia nigra(Moussa, Youdhim and Bakhle, 2006). 
5.3 Alzheimer’s disease  
In selected regions of the brain, there are deposits of the amyloid precursor protein, 
amyloid-ǃ (Aǃ) deposits in plaques and vessel walls and neuritic plaques (Liu et al., 2010). 
Amyloid precursor protein (APP) is the precursor of the neurotoxic Ab-amyloid. It contains 
an IRE in its mRNA which allows cellular levels of iron to control translation (Moussa, 
Youdhim and Bakhle, 2006). Gaeta and Hider (2005) reported that when the Aβ deposits 
accumulate sufficiently for oxidative stress to occur; it induces its own production, starting a 
vicious cycle. Also, there are structural lesions due to collapse of the neuronal cytoskeleton 
and accumulation of hyperphosphorylated and polyubiquinaed microtubule –associated 
proteins with formation of neurofibrillary tangles. Cerebral atrophy progressively becomes 
worse with loss of nerve fibres and cells and there is disconnection of the synaptic circuitry. 
There is activation of prodeath genes and signaling pathways;. Mitochondrial dysfunction 
occurs, energy metabolism is impaired and chronic oxidative stress is typical along with 
DNA damage (De la Monte and Wands 2008).  
Aǃ has multiple binding sites for iron and has greater affinity for Fe(II) than does 
transferrin. When Aǃ binds iron, ferric becomes more soluble and thus the Fe(III) present in 
complexes now becomes available to cellular reductants. This can disrupt iron homeostasis 
and perhaps is why iron is present along with Aǃ aggregates in senile plaques. Further, Aǃ 
may accumulate iron from the LIP. The implications of this in generating oxidative stress 
need further study (Jiang et al., 2009). In animal models increased iron worsened the course 
of increased risk of developing the disease. Data from postmortem pathology studies 
indicate iron deposition in neurons, neurofibrillary tangles and plaques of patients with AD. 
In vivo and in vitro studies show that amyloid protein aggregation was more and amyloid-
induced neuronal injury in human neuroblastoma cell line M1783 was worsened by iron 
(Stankewicz, 2007). Clinical trials with iron chelators showed favourable results in terms of 
decreased beta amyloid levels, improved cognition and living skills of patients lend support 
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to results of reduced toxicity in in vitro studies on neurons treated with iron chelator and 
then to beta amyloid (Stankewicz et al., 2007). 
6. Iron and liver 
Liver is the site of important metabolic pathways including detoxification of ammonia, 
alcohol and xenobiotics. It serves as a storage organ and acts as a filter by removing bacteria 
and debris through phagocytic action of Kupffer cells. Liver faces the onslaught of iron and 
is vulnerable to iron overload. Iron absorbed from food is first transported to the liver. 
Hepatocytes express TfR as well as its homolog, TfRII, both mediating the uptake of Tf-
bound iron. Unlike TfRI, TfRII lacks IRE and is not regulated reciprocally in response to iron 
levels, thereby allowing iron uptake by hepatocytes. Further, there are reports that 
hepatocytes can import iron by involving routes not involving TfRs. NTBI is absorbed 
primarily by liver via SLC39A zinc transporter–ZIP14 (Takami and Sakaida, 2011). Import of 
iron by more than one route, can contribute to iron loading in hepatocytes, thereby 
increasing their potential for iron-induced oxidative stress. Iron or iron-induced oxidative 
stress have also been found to activate cell signaling cascades triggering apoptosis and 
necrosis pathway via NF-κB and AP-1 pathways respectively. NF-κB promotes the synthesis 
and release of cytotoxic, proinflammatory and fibrogenic factors such as tumor necrosis 
factor (TNFǂ), IL-6 and MIP-1 that alter Kuppfer cells and hepatocyte function, and trigger 
hepatic stellar cell activation. In hepatic stellar cells, AP-1 transcription factors are involved 
in the regulation of procollagen (I). In addition, AP-1 and NF-κB-dependent gene products 
modulate hepatocyte death induced by oxidative stress (Zuwała-Jagiełło et al., 2011).  
 Oxidative stress leads to formation of glycoxidation products, including advanced glycation 
end products (AGEs) — among them Nε-(carboxymethyl) lysine and advanced oxidation 
protein products (AOPPs). Both AGEs and AOPPs trigger the inflammatory response via 
interaction with receptors for advanced glycation end products (RAGE). RAGE is a signal 
transduction receptor that binds both AGEs and AOPPs and by causing activation of NF-κB. 
In vitro experiments have shown that AGEs enhance transcription of genes for pro-
inflammatory cytokines such as IL-6 and TNF-ǂ. They may increase C-reactive protein 
(CRP) production. CRP is primarily produced byhepatocytes, and its chief inductor is the 
pro-inflammatory cytokine IL6. Glycosylated and oxidized proteins indirectly up-regulate 
CRP expression in hepatocytes by stimulating monocytes to produce IL-6 (Harrison-Findik, 
2007). Further iron catalyzes the formation of NO from peroxynitrite and can modulate gene 
expression in cells leading to altered cell functions (Zuwała-Jagiełło et al., 2011). 
Lipid peroxidation products such as 4-HNE and malondialdehyde can react with DNA 
bases and the ε-NH2 group of lysine and histidine residues. Acetaldehyde which is a 
product of ethanol oxidation, increases the binding of MDA and its own binding to proteins 
in a synergistic manner, resulting in the generation of new hybrid adducts i.e. MDA-
acetaldehyde adducts. These adducts may play a role in the development and progression 
of liver fibrosis as they have been shown to stimulate the secretion of several cytokines and 
chemokines by liver endothelial cells (Zuwała-Jagiełło et al., 2011).  
Oxidative stress is implicated in a number of pathological disorders. It is of importance that 
oxidative stress and associated liver disorders can influence iron metabolism and thereby 
have tremendous implications for further generation of ROS and exacerbation of disease. 
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Hepatic iron overload is common in many liver diseases where iron is a risk factor in 
disease progression (Hou et al., 2009). Hemochromatosis is a well-defined syndrome 
characterized by normal iron-driven erythropoiesis and toxic accumulation of iron in 
parenchymal cells of vital organs that can be caused by mutations in any gene that limits 
iron entry into the blood. 
6.1 Hepatitis C virus infection  
Hepatitis C virus (HCV) infection affects nearly 2% of the human population and is a major 
cause of liver disease worldwide. In majority of persons who suffered HCV infection, chronic 
state can be established which is often accompanied by alterations in liver function 
culminating in cirrhosis or hepatocellular carcinoma in 20% of infected individuals (Price and 
Kowdley, 2009). Total iron stores were reported to be elevated in patients with chronic 
hepatitis C compared to those with chronic hepatitis B, although in both sets of patients, the 
degree of necroinflammation did not differ (Muller et al., 2009). HCV infection more than 
hepatitis B infection has been reported to be associated with iron deposition, increased hepatic 
iron concentration, iron overload, increased serum Tf saturation, and serum ferritin. Franchini 
et al.,(2008) reported that chronic HCV infection is the main cause of hyperferritinemia.  
Elevation in iron indices was reported by Girelli et al., (2009) to be correlated with 
progression of liver disease. Iron is mostly deposited in Kupffer cells and portal 
macrophages and interferon therapy reduced hepatic iron. The authors stated that hepatic 
iron overload is a consequence of hepatocyte necrosis which releases ferritin from 
hepatocytes to be subsequently taken up by macrophages. Alternatively, these authors 
suggested that increased iron absorption may contribute to increased iron stores. Further, 
hepcidin levels are decreased which in turn increase the expression of FPN, thereby 
increasing iron transport in the duodenum, release by macrophages and accumulation of 
iron in the liver(Muller et al., 2009). Price and Kowdley (2009) reported that increased levels 
of TfRII on the hepatocyte membrane may increase iron uptake in chronic HCV infection.  
Excess iron which causes ROS generation, leads to lipid peroxidation, protein and DNA 
damage. The excess iron and lipid peroxidation products, such as 4-HNE can activate 
hepatic stellate cells as well as cause their proliferation and increase the synthesis of smooth 
muscle actin and collagen, all of which can contribute to hepatic fibrogenesis (Tanaka et al., 
2008). Increased 4-HNE levels upregulate procollagen and inhibits the expression of 
metalloproteinase – 1 gene. The latter plays an important role in degrading collagen. Thus, 
oxidative stress contributes to hepatic fibrosis (Gomez et al., 2010) 
Results of in vitro studies indicate that iron deposition in hepatocytes enhances HCV 
replication thereby aggravating the viral infection. Further, hepatocytic DNA damage 
results in accumulation of 8-hydroxy-2′-deoxyguanosine, which has been implicated in 
hepatocellular carcinoma. Muller et al., (2009) suggested that reducing body iron by 
phlebotomy or by consumption of a low iron diet may help to retard disease progression 
and risk of hepatoceullar carcinoma (Tanaka et al., 2008). 
6.2 Alcoholic liver disease (ALD)  
Alcohol related liver disease contribute substantially to disability and mortality, globally. 
Chronic alcohol consumption results in fatty liver, alcoholic hepatitis and cirrhosis and 
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manifests itself in ALD (Phillipe et al., 2007). Ethanol oxidation increases the NADH/ NAD+ 
ratio, which leads to increased fatty acid synthesis, inhibits ǃ-oxidation and the tricarboxylic 
acid cycle and increases the accumulation of triacylglycerols. Chronic alcohol consumption 
inhibits AMP kinase and activates sterol regulatory element binding protein-1, which 
increase lipogenesis resulting in hepatic steatosis(Mantena et al., 2008). Harrison-
Findik(2009) suggested that mitochondrial DNA damage and ribosomal defects may inhibit 
mitochondrial protein synthesis and compromise oxidative phosphorylation in chronic 
alcohol consumption. Mitochondrial dysfunction has been reported to possibly play an 
important role in development of non-alcoholic fatty liver disease (NAFLD) and non 
alcoholic steatohepatitis (NASH). 
Hou et al., (2009) reported that ingestion of even mild to moderate amounts of alcohol can 
increase iron overload, with the iron being localized in Kupffer cells and hepatocytes. On 
the other hand, alcohol metabolism to form acetaldehyde generates ROS. Thus iron and 
alcohol together contribute to and aggravate liver disease (Harrison-Findik, 2007). Although 
the mechanisms underlying iron accumulation are not well understood, it has been reported 
that alcohol-induced oxidative stress in hepatocytes downregulates hepcidin expression in 
liver, by altering transcription factor C/EBPǂ activity, thus dysregulating iron homeostasis 
(Hou et al., 2009; Harrison-Findik, 2009). To make matters worse, hepcidin expression is not 
responsive to body iron levels in alcohol consumption (Hou et al., 2009). H2O2 increases the 
expression of TfRI leading to iron accumulation and thus may support ALD progression 
(Girelli et al., 2009). 
6.3 Nonalcoholic fatty liver disease  
NAFLD is an important cause of liver damage ranging from fatty liver to nonalcoholic 
steatohepatitis (NASH). Simple steatosis is usually considered benign, but the development 
of NASH is recognized as a precursor of more severe liver disease, and in some cases, 
cirrhosis and hepatocellular carcinoma (Machado et al., 2009). Machado et al., (2009) 
reported that pathogenesis of NASH can be explained by the “two-hit” hypothesis, (a) 
insulin resistance and the resultant steatosis being the “first hit”. Hyperinsulinemia, 
increased peripheral lipolysis and reduced ǃ- oxidation lead to fat accumulation (b) the 
“second hit”- increased ROS/RNS. Once steatosis sets in, the liver progresses to more severe 
pathologic states when it is exposed to the second hit or other environmental stressors. Iron 
can increase the potential magnitude of the “second hit”. Genetic risk factors also influence 
the susceptibility and severity of fatty liver disease. 
Further, Fujita et al.,(2009) reported that NASH patients had elevated levels of hepatic 8-
oxodG which is is a DNA base-modified product generated by hydroxyl radicals. The level 
of this product was reduced by iron reduction therapy. These authors also reported that in 
steatosis, saturation of the ǃ-oxidation pathway with excess free fatty acids leads to further 
generation of H2O2, and other ROS. Also, serum iron, transferring saturation and ferritin 
levels were higher in NASH patients, which could be attributed to iron overload.  
The first hit i.e. insulin resistance has also been reported to be linked to iron overload, 
through mobilization of peripheral fat to the liver and development of hyperinsulinemia. 
Hyperinsulinemia and peripheral lipolysis promote hepatic uptake of fatty acids as well as 
fatty acid synthesis, resulting in accumulation of fat and fatty liver (Mantena et al., 2008). A 
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syndrome of “insulin resistance-associated iron overload” has proposed where in the 
presence of unexplained hepatic iron overload at least one component of the insulin 
resistance may be present. Insulin resistance also seemed to be closely linked to total body 
iron stores in the general population. Circulating prohepcidin was reported to be associated 
with parameters of glucose and iron metabolism, in subjects with altered glucose tolerance 
(Fujita et al., 2009). The researchers suggested that failure to increase synthesis of 
prohepcidin which can decrease iron absorption, could contribute to iron-induced disorders 
of glucose metabolism. Further support comes from reports that iron depletion can improve 
insulin sensitivity. ROS (induced by iron overload) can interfere with insulin signaling by 
inhibiting translocation of glucose transporter 4 to the plasma membrane, thus impairing 
insulin uptake. In insulin resistance, glycation of proteins including Tf occurs, which 
decreases its ability to bind ferrous iron, and increasing the free iron pool and amplifying 
oxidative stress (Fernandez-Real et al., 2009). Oxidative stress itself induces insulin 
resistance, thus creating a vicious cycle. 
7. Pros and cons of high iron intakes 
Normally in a well-nourished individual, the antioxidant defense mechanisms should 
protect against ROS injury, however in case of undernutrition, including micronutrient 
deficits, the antioxidant system would be compromised. In developing countries, anemic 
children, adolescents and women who receive iron supplements are also malnourished and 
chronically consume poor quality diets. During the life cycle, the individual is more 
vulnerable at certain life stages either because of physiological immaturity or senescence or 
due to alterations in physiology and metabolism as encountered in pregnancy. Thus infants, 
pregnant women and the elderly may be at higher risk, especially if their nutritional status 
is compromised by either deficiency or excess of any one nutrient.  
Iron supplementation is widely adopted since iron deficiency anemia is a global health 
problem. However, in public health systems, the issue of iron overload and its possible 
adverse consequences need to be paid attention in terms of well-designed studies and may 
need to be monitored closely, if deleterious effects are observed. There are reports in the 
literature on the effect of iron on the gastrointestinal tract, risk of cancer etc but these are not 
taken into account in public health programs. In animal models, iron-induced increase in 
oxidative damage was associated with gastric inflammation, induction of gastric ulcers and 
increase in colorectal cancer (Seril et al., 2002; Naito et al., 1995). In patients with Crohn’s 
disease treatment with 120 mg ferrous sulphate per day for 7 days increased clinical 
symptoms of disease activity (Erichsen et al., 2003). There is a dire need to examine the 
effects of iron deficiency, supplementation and their interaction on several parameters of 
oxidative stress, besides Hb which is routinely used as an indicator of iron deficiency 
anemia. In pregnancy, iron supplements are routinely recommended and there needs to be a 
consideration of the possible effects on ROS generation and pregnancy complications. Per 
se, the role of ROS in pregnancy in well-nourished and iron deficient women warrants 
attention. Fortification of foods with iron is adopted as an important public health measure 
to combat iron deficiency. When persons consume iron fortified foods, along with 
supplements, intakes could well be in excess of the recommended dietary allowances 
(RDA), which may pose risk for iron overload. Fisher and Naughton (2004) reported that 
daily intake of iron was 1874% of the Korean RDA for those who used supplements as 
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compared to 62% of the RDA for non-users. The potential for oxidative stress could be high, 
if vitamin C is co-ingested, especially through supplements and fortified foods. High 
concentration of iron taken as bolus dose along with reducing substances like vitamin C can 
have deleterious effects. Multivitamin/ multimineral complexes are most common 
supplements administered. Unlike minerals in food where they are part of bioorganic 
substances, minerals in supplements and in fortified foods are in inorganic forms. In this 
form, minerals are capable of catalyzing free radicals generation (Rabovsky et al., 2010). 
Hence there is a need to reformulate nutritional supplements to obtain the benefits while 
simultaneously minimizing the risks. 
A number of diseases have been shown to be associated with the intracellular accumulation of 
iron especially within mitochondria and lysosomes making them more susceptible to oxidative 
stress. Even a modest increase in the iron concentration in the substantia nigra may increase 
oxidative stress and neurodegeneration (Logroscino et al., 2008). Logroscino et al., (2008) 
stated that brain iron is responsive to peripheral iron status, hence brain iron status can be 
modulated by the iron content of the diet, both restriction and supplementation. The iron that 
accumulates in the brain is mostly nonheme iron. Case control studies and a prospective study 
in the US on suggest that dietary iron intake may be associated with higher risk of Parkinson’s 
disease. The prospective study on a cohort of 47,406 men and 76,947 women indicated that risk 
was greater for persons whose vitamin C intakes were lower. The risk for Parkinson’s disease 
was higher among those whose diets contained large amounts of non-heme iron primarily 
derived from fortified grains and cereals. Men were found to have some risk with the use of 
supplemental iron. The investigators did not find an association with heme iron ( Logroscino 
et al., 1998; Gorell et al., 1999; Powers et al., 2003). 
Besides this, with the growth of nanotechnology industry metallic nanoparticles are being 
increasingly used for variety of purposes including food products and medicines. 
Nanoparticles are able to cross semipermeable membrane via transcellular pathway. Since 
these particles are small in size and have a large surface area they will be highly reactive which 
in turn will increase their ability to produce ROS. Pujalté et al., (2011) have reported that 
metallic nanoparticles, such as, zinc oxide and cadmium sulphite exerted cytotoxic effects on 
glomerular and tubular renal cells. These effects were correlated with metal size and metal 
solubility. In an in vitro study, Apopa et al., (2009) have demonstrated that iron-nanoparticles 
induced an increase in endothelial cell permeability through the production of ROS. 
In summary, both iron deficiency and excess are risk factors for oxidative stress. The 
emphasis should be on well-balanced diets to meet the RDA of all essential nutrients as well 
as inclusion of foods rich in phytochemicals that provide protection against oxidative stress. 
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